↓ Skip to main content

Michigan Publishing

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective

Overview of attention for article published in The Lancet Respiratory Medicine, May 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
40 news outlets
blogs
1 blog
policy
1 policy source
twitter
21 X users
facebook
1 Facebook page

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
354 Mendeley
Title
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective
Published in
The Lancet Respiratory Medicine, May 2016
DOI 10.1016/s2213-2600(16)00094-1
Pubmed ID
Authors

MeiLan K Han, Carlos H Martinez, David H Au, Jean Bourbeau, Cynthia M Boyd, Richard Branson, Gerard J Criner, Ravi Kalhan, Thomas J Kallstrom, Angela King, Jerry A Krishnan, Suzanne C Lareau, Todd A Lee, Kathleen Lindell, David M Mannino, Fernando J Martinez, Catherine Meldrum, Valerie G Press, Byron Thomashow, Laura Tycon, Jamie Lamson Sullivan, John Walsh, Kevin C Wilson, Jean Wright, Barbara Yawn, Patrick M Zueger, Surya P Bhatt, Mark T Dransfield

Abstract

The burden of chronic obstructive pulmonary disease (COPD) in the USA continues to grow. Although progress has been made in the the development of diagnostics, therapeutics, and care guidelines, whether patients' quality of life is improved will ultimately depend on the actual implementation of care and an individual patient's access to that care. In this Commission, we summarise expert opinion from key stakeholders-patients, caregivers, and medical professionals, as well as representatives from health systems, insurance companies, and industry-to understand barriers to care delivery and propose potential solutions. Health care in the USA is delivered through a patchwork of provider networks, with a wide variation in access to care depending on a patient's insurance, geographical location, and socioeconomic status. Furthermore, Medicare's complicated coverage and reimbursement structure pose unique challenges for patients with chronic respiratory disease who might need access to several types of services. Throughout this Commission, recurring themes include poor guideline implementation among health-care providers and poor patient access to key treatments such as affordable maintenance drugs and pulmonary rehabilitation. Although much attention has recently been focused on the reduction of hospital readmissions for COPD exacerbations, health systems in the USA struggle to meet these goals, and methods to reduce readmissions have not been proven. There are no easy solutions, but engaging patients and innovative thinkers in the development of solutions is crucial. Financial incentives might be important in raising engagement of providers and health systems. Lowering co-pays for maintenance drugs could result in improved adherence and, ultimately, decreased overall health-care spending. Given the substantial geographical diversity, health systems will need to find their own solutions to improve care coordination and integration, until better data for interventions that are universally effective become available.

X Demographics

X Demographics

The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 354 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Unknown 352 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 57 16%
Student > Ph. D. Student 41 12%
Researcher 38 11%
Student > Bachelor 29 8%
Other 20 6%
Other 65 18%
Unknown 104 29%
Readers by discipline Count As %
Medicine and Dentistry 69 19%
Nursing and Health Professions 65 18%
Social Sciences 19 5%
Pharmacology, Toxicology and Pharmaceutical Science 15 4%
Engineering 11 3%
Other 62 18%
Unknown 113 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 330. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 September 2021.
All research outputs
#100,591
of 25,374,647 outputs
Outputs from The Lancet Respiratory Medicine
#147
of 2,867 outputs
Outputs of similar age
#2,022
of 327,280 outputs
Outputs of similar age from The Lancet Respiratory Medicine
#2
of 79 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,867 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 78.9. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 79 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.